Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Top Cited Papers
- 17 June 2011
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 12 (7), 663-672
- https://doi.org/10.1016/s1470-2045(11)70145-0
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART studyBritish Journal of Cancer, 2010
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Risk estimation for the next generation of prevention programmes for cervical cancerThe Lancet Oncology, 2009
- HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trialThe Lancet Oncology, 2009
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trialThe Lancet Oncology, 2008
- Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing CountriesVaccine, 2008
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsAmerican Journal of Obstetrics and Gynecology, 2007